Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 20/20 | 0.87 |
| ▸ | KCNH2 | Q12809 | 17/20 | 0.85 |
| ▸ | MCHR2 | Q969V1 | 7/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6340524 | 0.91 | MCHR1 (0.84) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6333436 | 0.91 | MCHR1 (0.87) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6337379 | 0.90 | MCHR1 (0.89) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6331421 | 0.90 | MCHR1 (0.79) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6337375 | 0.89 | MCHR1 (0.81) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6331277 | 0.87 | MCHR1 (0.78) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6332956 | 0.87 | MCHR1 (0.98) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL367622 | 0.87 | MCHR1 (0.84) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6332989 | 0.86 | MCHR1 (1.00) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6339148 | 0.86 | MCHR1 (0.82) | MCHR1KCNH2MCHR2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050209274-A1 | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor | ABOTT LABORATORIES | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209274-A1 | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor | MCHR1, MCHR2, MC1R | MCHR1 1/4885KCNH2 1620/4885MCHR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.